Whole genome sequencing (WGS) was performed to identify the variants responsible for inherited retinal degeneration (IRD) in a Caucasian family. Segregation analysis of selected rare variants with pathogenic potential identified a set of compound heterozygous changes p.Arg266*:c.796C>T and p.Ala568Thr:c.1702G>A in the intraflagellar transport protein-88 (IFT88) gene segregating with IRD. Expression of IFT88 with the p.Arg266* and p.Ala568Thr mutations in mIMDC3 cells by transient transfection and in HeLa cells by introducing the mutations using CRISPR-cas9 system suggested that both mutations result in the formation of abnormal ciliary structures. The introduction of the IFT88 p.Arg266* variant in the homozygous state in HeLa cells by CRISPR-Cas9 genome-editing revealed that the mutant transcript undergoes nonsense-mediated decay leading to a significant depletion of IFT88 transcript. Additionally, abnormal ciliogenesis was observed in these cells. These observations suggest that the rare and unique combination of IFT88 alleles observed in this study provide insight into the physiological role of IFT88 in humans and the likely mechanism underlying retinal pathology in the pedigree with IRD.
Introduction
A large number of genes associated with inherited retinal degeneration have been identified (RetNet, http://www. sph.uth.tmc.edu/RetNe t/). While these genes participate in a broad range of biological pathways, a substantial proportion of these genes encode ciliary proteins (Waters and Beales 2011) . Cilia are evolutionarily conserved organelles Anil Chekuri, Aditya A. Guru, Pooja Biswas authors contributed equally to this study.
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that play a key role in diverse biological functions (Marshall and Nonaka 2006) . Defects in ciliary structure and function are associated with several human pathologies, involving tissues in which primary cilia play a prominent role (Bisgrove and Yost 2006; Halbert et al. 1997; Pazour and Rosenbaum 2002; Wheway et al. 2014; Yoder 2007) . In the retina, photoreceptor cells contain specialized ciliary structures. Photoreceptor outer segments are joined to the photoreceptor inner segments by a connecting cilium (Khanna 2015; Liu et al. 2010) . Transport of proteins from the inner segment to the outer segment through the connecting cilium involves the intraflagellar transport (IFT) machinery composed of a group of IFT proteins . Mutations in genes encoding these IFT proteins lead to a set of inherited disorders known as ciliopathies, affecting several tissues including the eye, kidney and olfactory neurons (Bisgrove and Yost 2006; Waters and Beales 2011) . So far, mutations in 18 IFT proteins have been implicated in IRDs (Badano et al. 2006) .
Intraflagellar transport protein 88 (IFT88), a tetratricopeptide repeat containing protein is a core component of the IFT complex B, which is known to be involved in anterograde transport in cilia (Pazour et al. 2000) . IFT complex B is required for the assembly and maintenance of primary cilia and flagella across species ranging from unicellular organisms to high-order mammals (Mizuno et al. 2012; Rosenbaum and Witman 2002) . Besides its role in intraflagellary transport, IFT88 is also involved in additional biological activities including mitosis (Delaval et al. 2011) , hedgehog signaling (Chang and Serra 2013) , cell migration (Boehlke et al. 2015) and cell cycle progression (Kim and Tsiokas 2011) . Consistent with its multiple cellular functions, mouse models with mutant Ift88 developed severe pathology (Lehman et al. 2008) . Hypomorphic mutations in Ift88 were reported to cause polycystic kidney disease and photoreceptor degeneration [Tg737 orpk ] (Lehman et al. 2008; Moyer et al. 1994) . IFT88 null mutations result in embryonic lethality in mice (Murcia et al. 2000) . Conditional loss of Ift88 in the cranial neural crest cells of mice leads to craniofacial abnormalities and neonatal lethality (Tian et al. 2017) . Furthermore, the ciliogenesis was observed to be abnormal in IFT88 knock-out cell lines (Katoh et al. 2017) . Based on the crucial role of this gene in development and survival, it has been long considered a candidate for various human pathologies including ciliopathies, polycystic kidney disease, photoreceptor degeneration and craniofacial abnormalities (McIntyre et al. 2012; Pazour et al. 2002; Tian et al. 2017) . Thus far, mutations in IFT88 have not been confirmed to result in human disease.
In the present study, whole genome sequence analysis (WGS) of a family identified novel compound heterozygous mutations in IFT88 segregating with IRD. Further evaluation of the effect of these mutations by introducing them in HeLa cells by CRISPR-Cas9 mediated genome-editing and also by transiently transfecting mIMCD3 cells supported the involvement of these mutations in causing IRD and provided insight into the molecular pathology underlying IRD due to mutations in IFT88.
Results

Clinical analysis
Two female siblings (Fig. 1I ) of European ancestry reported impaired night vision beginning in the third and fourth decades (proband and sister). Vision impairment progressed for both, initially to mid-peripheral involvement and then to loss of central vision by the sixth and seventh decades. Patient III:I had a history of kidney stones. Her sister (patient III:II) was diagnosed with multiple sclerosis at age 43; she was also diagnosed with skin cancer and anemia, but denied any renal abnormalities. They reported no clinical or family history of other non-ocular abnormalities, including auditory disease, renal disease, craniofacial abnormalities or ciliopathy associated abnormalities. The sisters denied use of chloroquine or hydroxychloroquine. Color fundus images showed marked macular neuroretinal atrophy, but with some sparing of the fovea and only sparse intraretinal pigmented patches across the macular and temporal areas disproportionate to extent of RPE loss (Fig. 1II a, b) . Additionally, there was only modest optic disc pallor and mild attenuation of vascular arcades.
The proband (III:I) had progressive visual acuity loss from 20/25 at age 22 to 20/125 at age 63, and the sister (III:II) progressed from 20/30 at age 37 to 20/800 at age 58. By ages 63 and 58 (proband and sister), kinetic perimetry showed bilateral dense central scotomas out to the midperiphery, but with relative retention of fields further in the periphery to a Goldman III4e target ( Fig. 1II C and D) .
Electroretinography was performed on both affected siblings III:I and III:II at ages 42 and 38 years, respectively. In proband (III:I), the response to blue and white flash under scotopic conditions was severely reduced and the b-wave was delayed. The response under photopic conditions was also moderately reduced and cone response to 30 Hz flicker stimulation was markedly subnormal and delayed. In her younger sister (III:II) the rod isolated response was borderline normal. The combined rod-cone response had a borderline normal a-wave but the b-wave was selectively moderately reduced. The photopic response and cone response to 30 Hz flicker stimulus were moderately reduced with no delay. Taken together this suggests that proband (III:I) has moderate to severe rod and moderate cone dysfunction whilst at the time of examination patient III:II has mild rod dysfunction which is congruent with a cone-rod dystrophy (Fig S4) .
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Combined with the clinical histories, the sisters appear to have maintained central-most vision until later in the disease course and reported nyctalopia prior to developing the pericentral visual field loss, consistent with earlier compromise of rod rather than cone function. However, the pattern was anomalous for typical retinitis pigmentosa. The clinical features that the sisters exhibited resemble RP spectrum disease and have been described in the literature using terms including retinitis pigmentosa inversa (Ferrucci et al. 1998) , peri-central retinitis pigmentosa (Sandberg et al. 2005) , or progressive rod-cone dystrophy (Hartong et al. 2006) .
The father of the affected siblings did not manifest this condition, which is consistent with an autosomal recessive inheritance pattern. He experienced visual symptoms first in his ninth decade of life when he was diagnosed with dry macular degeneration. He showed no retinal pigmentary changes or atrophy beyond the central macula; his visual field was intact with only bilateral central loss mapping to his geographic atrophy, and his optic discs and retinal vasculature appeared normal.
Whole genome sequence analysis
Sequencing the genomes of both affected siblings and both parents of the RF.C.0804 pedigree generated ~ 900 million to 1150 million reads in each sample. After duplicates were removed, the mapped reads were estimated to cover the genome at an average depth of 42X. These reads were utilized to call variants, which identified about 4.5 million variants in each individual including 3.5 million single nucleotide polymorphisms (SNPs) and 1 million insertion-deletions (INDELs). From these, rare variants with a minor allele frequency < 0.005 in the 1000 Genomes project, a < 0.05 frequency in our in-house WGS dataset of 454 individuals from pedigrees with IRD, a score of deleteriousness by PolyPhen2, a high impact variant prediction by SNPEff or a CADD C-score ≥ 30 were selected for further analysis. This filtering strategy identified 450-512 rare and deleterious variants in each of the affected family members. The two affected siblings shared 237 of these rare and potentially pathogenic variants. None of these variants were found to be homozygous. Analysis of the compound heterozygous variants identified only one set of potential disease-causing variants, p.Arg266* (c.796C>T, rs145868877) and p.Ala568Thr (c.1702G>A) in the Intraflagellar transport protein 88 (IFT88) (NM_175605) segregating with disease. None of the previously known retinal dystrophy genes were identified to have potential disease-causing mutations in affected members of RF.C.0804 pedigree.
Mutation segregation analysis and control individuals screening
The dideoxy sequencing analysis of variants p.Arg266* (c.796C>T) in exon 13 and p.Ala568Thr (c.1702G>A) in exon 20 of IFT88 demonstrated co-segregation of these variants with disease in RF.C.0804 family (Fig. 1I ). The nonsense variant p.Arg266* was found to be heterozygous in the mother and both affected siblings (Fig. 1I ). This variant may result in premature truncation of IFT88 leading to the loss of 561 C-terminal amino acids (Fig. 1IV ). IFT88 is predicted to have two coiled domains and 10 tetratricopeptide repeat motifs (Fig. 1IV) (Bhogaraju et al. 2013) . Therefore, if the p.Arg266* stop gain mutation results in termination of IFT88 at the 266 amino acid, the truncated protein will lose 6 of the 10 tetratricopeptide repeats that are part of the second coiled coil domain. Alternatively, the nonsense variant may result in nonsense-mediated decay (NMD) of the transcript, causing the loss of IFT88 protein. The missense variant p.Ala568Thr was observed to be heterozygous in the father and both affected sisters ( Fig. 1I ) and is located in a highly conserved region of IFT88 (Fig. S2 ). This variant was predicted to be pathogenic by PolyPhen2 (Adzhubei et al. 2013) and SIFT (Hu and Ng 2013) and the presence of this variant may alter the structure of the protein. Structural models indicate the location of p.Ala568Thr to be in the middle of helix A of a two helix repeat within a larger right-handed super helical fold (Fig. S1 ). The presence of the variant in this location suggests that it could be damaging as a result of the added bulk of the threonine side chain relative to either the adjoining helix B or the adjacent helix A', though the two models evaluated provide conflicting evidence for this hypothesis.
The frequency of both variants c.796C>T (p.Arg266*; ExAC: 0.000009984) and c.1702G>A (p.Ala568Thr; ExAC: 0.00002166) were reported to be very low in the population. Neither of these two variants nor additional damaging variants in IFT88 were detected in our laboratory WGS database which contained a total of 800 individuals (including 454 individuals from IRD pedigrees). Similarly, the variant data sets of a cohort of 150 genetically unexplained inherited retinal disease probands from the Netherlands (Radboud University Nijmegen Medical Center), 618 from Japan and 117 from Pakistan were screened. Neither of the two potential disease-causing variants observed in this study nor any additional pathogenic variants were detected in IFT88. Furthermore, screening 50 probands of Indian origin and obtaining a diagnosis of IRD by dideoxy sequencing also yielded similar findings indicating that the occurrence of pathogenic changes in this gene is not a common event.
Expression and localization of wild type and mutant IFT88 in mIMCD3 cells
IFT88 is a ciliary protein and is critical for ciliogenesis in a wide variety of sensory cells (Murcia et al. 2000; Pazour et al. 2000) . Therefore, to study the effect of p.Arg266* and p.Ala568Thr mutations, ciliated mIMCD3 cells were Fig. 2 Localization of wild type and mutant IFT88 in transiently transfected mIMCD3 cells. mIMCD3 cells transiently transfected with wild type IFT88-GFP, p.Arg266* IFT88-Myc and p.Ala568Thr IFT88-Myc were analyzed. Immunostaining was performed with anti-Myc antibody (green) and acetylated alpha tubulin (red) a ciliary marker. The nucleus was stained with DAPI (blue). a-c Mock-transfected HeLa cells were stained acetyl tubulin showed normal cilia. d-f Wild type IFT88 (green) was localized to the tip and the base of the cilium (red) (g-i) co-Immunostaining with both acetyl tubulin and IFT88 showed mislocalization of both p.Arg266* IFT88 and j-l p.Ala568Thr IFT88 (green) away from the cilia. m Ciliary length of cells expressing wild type IFT88-GFP, p.Arg266* IFT88-Myc and p.Ala568Thr IFT88-Myc were measured using image J (NIH, USA). (Color figure online) ◂ transiently transfected with GFP-tagged wild type-IFT88 (Fig. 2) or Myc-tagged Arg266*-IFT88 (Fig. 2) or Myctagged Ala568Thr-IFT88 (Fig. 2) constructs. An additional set of mock-transfected mIMCD3 cells were analyzed as controls (Fig. 2) . Cells transfected with wild type-IFT88-GFP showed normal ciliary length when stained with acetylated tubulin (Fig. 2) and the GFP signal representing the wild type IFT88 co-localized with the basal body and the distal tip of the cilia as reported earlier (Robert et al. 2007 ). In contrast, the cells transfected with Arg266*-IFT88-Myc or Ala568Thr-IFT88-Myc constructs exhibited extra-ciliary localization of the protein (Fig. 2) . In addition, the length of cilia in cells expressing Myc-tagged Arg266*-IFT88 or Myc-tagged Ala568Thr-IFT88 constructs were found to be significantly shorter (P < 0.0001) when compared to cells expressing wild type-IFT88 (Fig. 2) indicating defective ciliogenesis in these cells. The mock-transfected cells did not show GFP signal or immunostaining with anti-Myc antibodies. The cilia were found to be normal in these cells. These results suggest that both the p.Arg266* and p.Ala568Thr mutations result in mislocalization of IFT88 and abnormal cilia in transiently transfected mammalian cells.
Analysis of the consequences of IFT88 p.Arg266* and p.Ala568Thr mutations
To understand the impact of IFT88 mutations, p.Arg266* and p.Ala568Thr, the genomes of HeLa cells were edited using CRISPR-Cas9 system. This resulted in the generation of HeLa cells with the homozygous p.Arg266* nonsense mutation and the homozygous p.Ala568Thr missense mutation in IFT88. In addition, a clone with the homozygous p.Arg266Glufs*2 mutation in IFT88 was also identified. All three cell lines were used to study the effect of mutation on IFT88 expression and ciliogenesis. The p.Arg266* and p.Arg266Glufs*2 mutations located in exon 13 of IFT88 could result in the formation of a truncated protein or in the loss of IFT88 due to the nonsense-mediated decay (NMD) of the transcript. The Arg266*-IFT88-Myc construct used for transient transfection studies does not allow the examination of NMD of the mutant transcript. Therefore, the genome-edited HeLa cells with the p.Arg266* mutation were studied to examine if the nonsense mutation located in exon 13 resulted in the loss of IFT88 due to NMD. Similarly, the second clone (clone 2) identified with a different stop codon due to the p.Arg266Glufs*2 mutation was also analyzed to further evaluate the impact of nonsense changes in exon 13 of IFT88.
To examine the effect of p.Arg266*, p.Arg266Glufs*2 and p.Ala568Thr mutations on cellular morphology and ciliogenesis, the genome-edited HeLa cells harboring these mutations and the control HeLa cells were stained with the primary cilia marker acetylated alpha tubulin. The majority of normal control HeLa cells (Fig. 3a ) (> 90%) had normal appearing primary cilia as reported previously (McIntyre et al. 2012) . However, examination of the two independent clones of genome-edited HeLa cells harboring the homozygous p.Arg266* and p.Arg266Glufs*2 mutations revealed that only 15-20% of these cells showed significantly stunted cilia while the remaining cells showed minimal or no ciliary structures (Fig. 3b, c) . Similarly, shortened ciliary structure along with mislocalization of IFT88 observed in 40% of the edited cells with p.Ala568Thr mutation (Fig. 3d) . However, most of the cells (~ 50%) with p.Ala568Thr mutation were lacking the complete cilia while the presence of IFT88 was observed in some of those cells.
Western blot analysis of the lysates of genomeedited HeLa cells harboring homozygous p.Arg266*, p.Arg266Glufs*2 and p.Ala568Thr mutations were carried out to study the IFT88 protein. Immunostaining with IFT88 antibodies raised against the C-terminal region of IFT88 did not detect the presence of protein in either cell line carrying the homozygous nonsense mutations in IFT88 (Fig. 4a,  lanes 2 and 4) . Whereas, an immune positive band corresponding to wild type IFT88 was observed in the lysates of HeLa cells with the p.Ala568Thr mutation similar to the control and mock-transfected HeLa cells (Fig. 4a, lanes 1,  3 and c) . The failure to detect an immunoreactive band in the lysates of genome-edited cells with the p.Arg266* and p.Arg266Glufs*2 mutations indicated either the absence of mutant protein or the formation of a truncated protein which did not have immunoreactivity to the IFT88 C-terminal region antibodies used.
Analysis of the expression of p.Arg266*-IFT88 and p. Arg266Glufs*2-IFT88 transcript
The IFT88 transcript levels were measured in HeLa cells with the homozygous mutations p.Arg266* and p.Arg266Glufs*2 in IFT88 (ENST00000319980.6) and compared with the levels in wild type and the mock-transfected HeLa cells. The levels of IFT88 transcript in both cell lines with the IFT88 mutations were found to be significantly low compared to the levels in wild type and mock-transfected cells (P < 0.0001) (Fig. 4b) suggesting that the mutations resulted in the depletion of IFT88.
To further study the possible involvement of NMD of the nonsense mutation p.Arg266*, the wild type, the mock-transfected and the genome-edited HeLa cells with the homozygous p.Arg266* mutation were treated with cycloheximide. No significant difference was observed in the levels of IFT88 transcript in cycloheximide-treated wild type and mock-transfected HeLa cells compared to the levels in untreated cells (Fig. 5) . However, the levels of Arg266*-IFT88 transcript were found to increase significantly in HeLa cells with the homozygous Arg266*-IFT88 mutation following cycloheximide treatment (Fig. 5) . The low levels of mutant transcript and the accumulation of this transcript upon treatment with cycloheximide in CRISPR/Cas9 edited HeLa cells with p.Arg266*-IFT88 mutation suggests the possible involvement of nonsense-mediated decay in the depletion of this transcript (Durand et al. 2007 ).
Analysis of off-target effects due to CRISPR-Cas9 genome-editing in HeLa cells
In order to investigate the possible off-target changes introduced into the genomes of HeLa cells with the p.Arg266* and p.Arg266Glufs*2 variants, the off-target sites were identified. This analysis revealed several candidate off-target genomic regions in cells transfected with CRISPR OFP nuclease vector expressing gRNA. Five regions with the highest off-target score were selected for analysis (Table S1 ). Sanger sequencing confirmed no off-target activity at these potential off-target sites. Therefore, the changes observed in these cells are likely due to the homozygous p.Arg266* or p.Arg266Glufs*2 variants in IFT88.
Discussion
Whole genome sequence analysis was conducted on a family with IRD and identified compound heterozygous mutations in IFT88, which segregated with retinal degeneration (Fig. 1I) . In this family, no other potentially pathogenic mutations were identified in any of the known IRD genes suggesting that the IFT88 mutations are the likely underlying cause of retinal degeneration.
In photoreceptors, IFTs are responsible for the transport of proteins between the inner and outer segments. Mutations in genes that code for five different IFTs (IFT172, IFT144, IFT140, IFT43 and IFT38) are known to cause human retinal degeneration (Biswas et al. 2017; Bujakowska et al. 2015; Dharmat et al. 2017; Lehman et al. 2008; Xu et al. 2015) . The well-established role of IFTs in photoreceptor degeneration and segregation of these novel IFT88 mutations with IRD in the RF.C.0804 pedigree supports the addition of IFT88 to the list of IFTs implicated in human disease.
IFT88, one of the well-studied members of the IFT complex, has been considered a candidate gene for human ciliopathy associated phenotypes due to its critical role in cilia, and involvement in retinal degeneration and kidney abnormalities in the ORPK mice (Lehman et al. 2008) . Targeted screening of IFT88 for mutations in a cohort of fetuses and individuals with severe ciliopathies identified a homozygous missense variant p.Met383Lys in one fetus of European ancestry with renal and hepatic cysts and without polydactyly or encephalocele (McIntyre et al. 2012 ). This missense variant (p.Met383Lys) was reported to result in the loss of functional IFT88 in a zebrafish model (McIntyre et al. 2012) . The frequency of this variant was reported to be very low in individuals of European ancestry (0.000115) while it is more common in the South Asian population (frequency = 0.0285) with 10 homozygous individuals listed in the ExAC database. Furthermore, an additional missense variant, p.Met383Ile (rs2442455), involving the same codon was reported to be a common polymorphism in various populations (ExAC database). This indicates that the Methionine at 383 in IFT88 is not critical for the normal function of this protein in humans. Based on these findings it is not clear if the homozygous p.Met383Lys variant in IFT88 alone is sufficient to cause pathology in the fetus with ciliopathy associated phenotype.
In a more recent study, IFT88 has been suggested as a candidate gene for autosomal dominant craniofacial abnormalities with variable penetrance (Tian et al. 2017) . Review of the clinical data of patients in our study pedigree RF.C.0804 revealed a history of kidney stones in one of the affected siblings (III:I) while the other affected individual lacked any kidney abnormalities. Neither of these patients reported other symptoms associated with ciliopathy. Additionally, evaluation of the clinical history of all members of RF.C.0804 pedigree did not reveal the presence of craniofacial abnormalities or known family history of such abnormalities. It is likely that the two IFT88 mutations observed in RF.C.0804 pedigree are not associated with non-ocular phenotypes.
Determining the functional impact of the human mutations p.Arg266* and p.Ala568Thr in IFT88 will reveal the possible mechanism underlying IRD due to these mutations. Mutations in several ciliary proteins affect ciliogenesis and cause severe diseases or embryonic lethality (CardenasRodriguez and Badano 2009). Mouse models for a large Fig. 5 Nonsense-mediated decay of IFT88 transcript in cells with the homozygous p.Arg266* mutation. The levels of IFT88 transcript in mock-transfected, control HeLa cells without (IFT88-control-U) or with cycloheximide treatment (IFT88-control-T) and after recovery (IFT88-control-R) were found to be similar. A significant increase in the levels of IFT88 transcript was observed in response to treatment with cycloheximide in cells carrying the IFT88 p.Arg266* mutation (IFT88-R266*-T) compared to untreated cells (IFT88-R266*-U). In these cells, the levels of IFT88 transcript were found to be significantly lower after recovery (IFT88-R266*-R) compared to the levels observed in cycloheximide-treated cells (IFT88-R266*-T) (P < 0.0001) number of IFT null alleles are embryonic lethal (McIntyre et al. 2012 ). In IFT88, 53 loss-of-function alleles are listed in the gnomAD database (accessed on 12-22-17) with a frequency < 0.00005. None of the loss-of-function alleles were reported in the homozygous state in this database. In addition, pathogenic compound heterozygous mutations have also not been previously reported in patients. These suggest that, severely damaging homozygous or compound heterozygous IFT88 alleles are perhaps embryonic lethal in humans also. In affected members of RF.C.0804 pedigree with IFT88 compound heterozygous mutations p.Arg266* and p.Ala568Thr, the nonsense mutation may result in the loss of one allele of IFT88 while the second missense mutation may generate a hypomorphic allele, which may enable the person to escape developmental abnormalities and embryonic lethality. However, the lack of normal ciliary transport due to the heterozygous p.Ala568Thr mutation in IFT88 in addition to the depletion of the second IFT88 allele due to the heterozygous p.Arg266* mutation together may lead to photoreceptor degeneration observed in patients by 3rd or 4th decade. Furthermore, these mutations may also have an impact on the non-ciliary functions of IFT88 contributing to the phenotype. The rare occurrence of the unique set of compound heterozygous variants observed in this study may provide insight into the physiological role of IFT88 in humans. Additional studies using patient iPSC derived photoreceptor cells or retinal organoid models and mouse models with the p.Arg266* and p.Ala568Thr mutations in IFT88 may provide a deeper understanding of the mechanism underlying the IRD due to these mutations.
Materials and methods
Clinical studies
The family history, medical history and blood samples were collected from the available members (II:I, II:II, III:I and III:II) of family RF.C.0804 (Fig. 1I) . A complete history was obtained from two affected siblings (III:I and III:II) and their father (II:II). Both affected individuals (III:I and III:II) underwent a complete ophthalmic evaluation which included fundus photography, kinetic visual fields and visual acuity (VA) measurements as described earlier (Biswas et al. 2016) . Full field electroretinograms (ERG) were recorded with corneal electrodes after pupil dilation. Ganzfeld ERGs were performed for brief xenon flash stimuli. After 45-min of dark-adaptation scotopic recordings were performed using dim blue stimuli (− 1.82 log cd-s/m 2 ) and brighter white stimuli (0.83 log cd-s/m 2 ). After 10 min of light adaptation to a white 42 cd/m 2 rod-saturating background, single flash and 30 Hz flicker ERGs were recorded for white stimuli (0.83 log cd-s/m 2 ).
All studies on patients were carried out in accordance with the declaration of Helsinki and with the approval of the Institutional Review Boards of the University of California San Diego and the University of Michigan.
Genome data analysis
DNA was isolated from the blood samples of both affected siblings (III:I and III:II) and their parents (II:I and II:II) using the Qiagen DNeasy kit (Qiagen, Gaithersburg, MD). Whole genome sequencing was performed on the DNA of the four members of the pedigree using the Illumina HiSeq X10 (Illumina, San Diego, CA, USA) to generate 150 bp paired end reads at an average read depth of 42×. The following steps were carried out as described previously (Gustafson et al. 2017) . Reads were aligned against human genome hg19 and decoy sequences using BWA-MEM, then marked duplicates with Biobambam2 as described previously (Li and Durbin 2009) . Single nucleotide variants (SNVs) and insertion-deletion variants (INDELs) were called using the Genome Analysis Tool Kit (GATK) best-practice pipeline. SNVs were then annotated using SnpEff, PolyPhen2, and CADD. Structural variants in the genome (SVs) were called with GenomeStrip and SpeedSEq. Variants were filtered to identify rare (< 0.005), potentially pathogenic changes in genes expressed in eye tissue and consistent with the pattern of inheritance (Branham et al. 2016 ).
Mutation segregation analysis and control screening
Sequence alterations identified as potentially disease-causing variants were validated by dideoxy sequencing in all available members (II:I, II:II, III:I and III:II) of the family as described earlier using the primers listed in Table S1 (Branham et al. 2016) . A set of 800 individuals (including 454 individuals from IRD pedigrees and 346 ethnicitymatched controls) in our laboratory WGS data set, and the WES data of 150 from Netherlands, 618 from Japan and 117 from Pakistan with IRD were analyzed for IFT88 mutations using methods described previously (Gustafson et al. 2017 ).
Designing of IFT88 constructs
A GFP-tagged wild type IFT88 construct was purchased from Origene (Rockville, MD) and mutant plasmids were designed in-house for further studies. The p.Ala568Thr (c.1702G>A) missense mutation and nonsense mutation p.Arg266* (c.796C>T) were introduced into the IFT88 wild type construct using site-directed mutagenesis as described earlier (Biswas et al. 2016) . Both constructs were designed to express fusion proteins with a Myc tag at the C-terminus in the pCMV6-Entry Mammalian Destination vector and produced by GENEWIZ (GENEWIZ Inc., La Jolla, CA).
Localization of IFT88 protein in transfected cells
The mIMCD3 cells transfected with the wild type and mutant IFT88 constructs were collected 48-h post-transfection, briefly washed in ice cold PBS and fixed with 4% paraformaldehyde. The localization of the mutant IFT88 was detected by immunostaining using anti-Myc mAb (1:500) (9B11, Cell Signaling Danvers,MA). Wild type IFT88 was detected by GFP expression. Cilia were stained with acetylated alpha tubulin antibody (Santa Cruz biotechnologies, Dallas, TX) and DAPI (Vector Labs, Burlingame, CA) was used to counterstain nuclei. Images were captured using Nikon a confocal microscope system (A1R STORM, Melville, NY, USA). Length of cila was measured using Image J software (NIH USA).
Generation of HeLa cells with p.Arg266*-IFT88 and p.Ala568Thr mutations using CRISPR/Cas9 system
Several gRNA expression vectors were designed to introduce the c.796C>T and c.1702G>A mutations in IFT88 into HeLa cells by cloning the guide RNA (gRNA) sequences 5′-GAA CTT GGT CTA ATG CCA TT-3′ and 5′-TAT CTT ATT TGA AAA CCT TA-3′ into a GeneArt CRISPR nuclease vector tagged with an orange fluorescent protein (OFP) (ThermoFisher, Carlsbad, CA). This construct was used to introduce c.796C>T and c.1702G>A mutations in IFT88 gene, respectively. HeLa cells were transfected with the gRNA expression vector and homology directed repair templates which incorporated a protospacer adjacent motifmodified sequences 5′-CTA TTG TTA TAA ACT TAC CTC  ATT TGC TTA TTG ACA CTT GGA ACT TGG TCT AAT GCC  ATT CaaTAG AAT TTA ATG GCT TTG GAA TAA TTT CTT  TGC TTT AAA TAG ATA TTT CCC ATA TTCA-3′ and CCT  TAC CTA TGA GAA ACT AAA TCG GCT AGA TGA GGC  TTT GGA CTG TTT CCT GAA ACT TCA CGC AAT CCT ACG  AAA CAG TGC CGA AGT TCT TTA CCA GAT AAC AAA  TAT GTA TCT TAT TTG AAA ACC TTA GGA ACA GTT ATT  AAT TCT CTC AAT TGG TGA TTG AAG ATC AAT TAT TAA ATA AGT TTA ACT AAT GAA GTA AT for the generation of HeLa cells with c.796C>T and c.1702G>A mutations in IFT88, respectively (synthesized by Thermo Fisher Scientific, Carlsbad, CA) using Lipofectamine 3000 (Thermo Fisher, Carlsbad, CA). 48 h after transfection, the OFP positive cells were sorted into a 96 well plate with one cell per well using BD FACSAria (BD Biosciences, Franklin Lakes, NJ). 68 wells were screened for mutations by amplifying and sequencing exon 13 of IFT88. One clone (clone 1) with the homozygous p.Arg266* (c.796C>T) mutation was identified. In addition, another clone (Clone 2) with a homozygous c.796delC mutation in IFT88, which creates a stop codon (p.Arg266Glufs*2) two amino acids downstream to the p.Arg266*, was identified. Similarly, a clone with the homozygous mutation p.Ala568Thr (1702G>A) in exon 20 of IFT88 was also identified. All three clones were clonally expanded. The presence of the mutations in the homozygous state in IFT88 exon 13 and 20 were confirmed by amplification and sequencing the DNA from all clones. The expression of Arg266*-IFT88, Arg266Glufs*2-IFT88 and p.Ala568Thr-IFT88 were studied by western blot analysis of cell lysates using an IFT88 antibody (1:200) (13967-1-AP, Proteintech Group, Inc, Rosemont, IL 60018, USA).
Analysis of CRISPR nuclease vector-transfected cells for non-specific changes in the genome
Genomic regions prone to off-target changes by CRISPR nuclease in the HeLa cell line with the homozygous p.Arg266* IFT88 mutation were identified by in silico analysis using the cutting frequency determination (CFD) score method employing Benchling software (Benchling, San Francisco, CA) (Doench et al. 2016) . Regions identified as potential off-target sites were examined for sequence changes by amplification and sequencing as described earlier (Hsu et al. 2013 ). The primers used for amplification of the selected regions are listed in Table S1 .
Analysis of the expression of mutant IFT88 transcript
Levels of IFT88 transcript were studied in control HeLa cells, mock-transfected cells expressing the wild type IFT88 and the cells with the homozygous p.Arg266* and p.Arg266Glufs*2 mutations to understand the impact of mutations that result in stop codons in exon 13 of IFT88. In addition, the HeLa cells (clone 1) with the p.Arg266* human mutation were treated with 100ug/ml cycloheximide (SigmaAldrich, Carlsbad CA) followed by incubation in serum containing medium to evaluate the potential involvement of nonsense-mediated decay in abrogation of p.Arg266*-IFT88 (Durand et al. 2007) . RNA was isolated from these cells using Qiagen RNeasy Mini Kit (Qiagen, German town MD). Preparation of cDNA using reverse transcriptase and quantitative RT-PCR relative to the housekeeping genes GAPDH and ACTB were performed as described previously.
Statistical analysis
Experimental data were represented as means ± standard deviation. Statistical significance was analyzed using Student's t test. The P value less than 0.0001 (P < 0.0001) was indicated by *** and determined as statistically significant.
